Epithelial-to-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of ALK Mutation Status.
暂无分享,去创建一个
Y. Ishikawa | Ryohei Katayama | T. Nakagawa | S. Yano | M. Nishio | K. Fukuda | H. Taniguchi | S. Takeuchi | Tadaaki Yamada | S. Nanjo | H. Ninomiya | K. Takeuchi | A. Horiike | N. Yanagitani | H. Nishihara | S. Arai | Takeshisa Suzuki | Azusa Tanimoto | A. Nishiyama | Satoko Baba